Burkitt lymphoma: The role of Epstein-Barr virus revisited

British Journal of Haematology

Volumn 156, Issue 6, 2012, Pages 719-729

  Grömminger, Sebastian ^a   Mautner, Josef ^a   Bornkamm, Georg W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Burkitt lymphoma; Epstein Barr virus; Infectious disease

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; MICRORNA;

ANTIBODY TITER; APOPTOSIS; B LYMPHOCYTE; BCL2L11 GENE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER RISK; EBER1 GENE; EBER2 GENE; EBNA1 GENE; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE PRODUCT; HERPES SIMPLEX VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE PROLIFERATION; MALARIA; MEMORY CELL; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SOMATIC HYPERMUTATION; T LYMPHOCYTE; TP53 GENE; TUMOR VIRUS; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS GENE; VIRUS REACTIVATION; VIRUS REPLICATION;

BURKITT LYMPHOMA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTIOUS MONONUCLEOSIS;

EID: 84857788752     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.09007.x     Document Type: Review

References (102)

1. Adhikary, D., Behrends, U., Moosmann, A., Witter, K., Bornkamm, G.W. & Mautner, J. (2006) Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. Journal of Experimental Medicine, 203, 995-1006.
2. Anderton, E., Yee, J., Smith, P., Crook, T., White, R.E. & Allday, M.J. (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene, 27, 421-433.
3. Babcock, G.J., Decker, L.L., Freeman, R.B. & Thorley-Lawson, D.A. (1999) Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. Journal of Experimental Medicine, 190, 567-576.
4. Barth, S., Meister, G. & Grasser, F.A. (2011) EBV-encoded miRNAs. Biochimica et Biophysica Acta, 1809, 631-640.
5. Bornkamm, G.W., Stein, H., Lennert, K., Ruggeberg, F., Bartels, H. & zur Hausen, H. (1976) Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. International Journal of Cancer, 17, 177-181.
6. Brooks, L.A., Lear, A.L., Young, L.S. & Rickinson, A.B. (1993) Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. Journal of Virology, 67, 3182-3190.
7. Burkitt, D. (1958) A sarcoma involving the jaws in African children. British Journal of Surgery, 46, 218-223.
8. Burkitt, D. (1962) Determining the climatic limitations of a children's cancer common in Africa. British Journal of Medicine, 2, 1019-1023.
9. Burkitt, D., Hutt, M.S. & Wright, D.H. (1965) The African Lymphoma: preliminary Observations on Response to Therapy. Cancer, 18, 399-410.
10. Chang, D.W., Claassen, G.F., Hann, S.R. & Cole, M.D. (2000) The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Molecular and Cellular Biology, 20, 4309-4319.
11. Chene, A., Donati, D., Guerreiro-Cacais, A.O., Levitsky, V., Chen, Q., Falk, K.I., Orem, J., Kironde, F., Wahlgren, M. & Bejarano, M.T. (2007) A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathogens, 3, e80.
12. Choy, E.Y., Siu, K.L., Kok, K.H., Lung, R.W., Tsang, C.M., To, K.F., Kwong, D.L., Tsao, S.W. & Jin, D.Y. (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. Journal of Experimental Medicine, 205, 2551-2560.
13. Clybouw, C., McHichi, B., Mouhamad, S., Auffredou, M.T., Bourgeade, M.F., Sharma, S., Leca, G. & Vazquez, A. (2005) EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis. Journal of Immunology, 175, 2968-2973.
14. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R.C. & Croce, C.M. (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America, 79, 7824-7827.
15. Dalldorf, G., Linsell, C.A., Barnhart, F.E. & Martyn, R. (1964) An Epidemiologic Approach to the Lymphomas of African Children and Burkitt's Sacroma of the Jaws. Perspectives in Biology and Medicine, 7, 435-449.
16. Donati, D., Zhang, L.P., Chene, A., Chen, Q., Flick, K., Nystrom, M., Wahlgren, M. & Bejarano, M.T. (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infection and Immunity, 72, 5412-5418.
17. Donati, D., Espmark, E., Kironde, F., Mbidde, E.K., Kamya, M., Lundkvist, A., Wahlgren, M., Bejarano, M.T. & Falk, K.I. (2006) Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. Journal of Infectious Diseases, 193, 971-977.
18. Egle, A., Harris, A.W., Bouillet, P. & Cory, S. (2004) Bim is a suppressor of Myc-induced mouse B cell leukemia. Proceedings of the National Academy of Sciences of the United States of America, 101, 6164-6169.
19. Eischen, C.M., Weber, J.D., Roussel, M.F., Sherr, C.J. & Cleveland, J.L. (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes and Development, 13, 2658-2669.
20. Epstein, M.A., Achong, B.G. & Barr, Y.M. (1964) Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet, 1, 702-703.
21. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. & Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
22. Fernandez, P.C., Frank, S.R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A. & Amati, B. (2003) Genomic targets of the human c-Myc protein. Genes and Development, 17, 1115-1129.
23. Fischer, S.F., Bouillet, P., O'Donnell, K., Light, A., Tarlinton, D.M. & Strasser, A. (2007) Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood, 110, 3978-3984.
24. Fox, C.P., Shannon-Lowe, C. & Rowe, M. (2011) Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae, 2, 8.
25. Goossens, T., Klein, U. & Kuppers, R. (1998) Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proceedings of the National Academy of Sciences of the United States of America, 95, 2463-2468.
26. Gratama, J.W., Oosterveer, M.A., Lepoutre, J., van Rood, J.J., Zwaan, F.E., Vossen, J.M., Kapsenberg, J.G., Klein, G. & Ernberg, I. (1989) Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. Transplantation Proceedings, 21, 3097-3098.
27. Greenspan, J.S., Greenspan, D., Lennette, E.T., Abrams, D.I., Conant, M.A., Petersen, V. & Freese, U.K. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. New England Journal of Medicine, 313, 1564-1571.
28. Gregorovic, G., Bosshard, R., Karstegl, C.E., White, R.E., Pattle, S., Chiang, A.K., Dittrich-Breiholz, O., Kracht, M., Russ, R. & Farrell, P.J. (2011) Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines. Journal of Virology, 85, 3535-3545.
29. Gruhne, B., Sompallae, R., Marescotti, D., Kamranvar, S.A., Gastaldello, S. & Masucci, M.G. (2009) The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America, 106, 2313-2318.
30. Hanto, D.W., Frizzera, G., Purtilo, D.T., Sakamoto, K., Sullivan, J.L., Saemundsen, A.K., Klein, G., Simmons, R.L. & Najarian, J.S. (1981) Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Research, 41, 4253-4261.
31. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P. & Santesson, L. (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature, 228, 1056-1058.
32. Hemann, M.T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J.A., Cordon-Cardo, C., Cleveland, J.L., Tansey, W.P. & Lowe, S.W. (2005) Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature, 436, 807-811.
33. Henle, G. & Henle, W. (1966) Immunofluorescence in cells derived from Burkitt's lymphoma. Journal of Bacteriology, 91, 1248-1256.
34. Henle, G. & Henle, W. (1970) Observations on childhood infections with the Epstein-Barr virus. Journal of Infectious Diseases, 121, 303-310.
35. Henle, W., Diehl, V., Kohn, G., Zur Hausen, H. & Henle, G. (1967) Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science, 157, 1064-1065.
36. Henle, G., Henle, W. & Diehl, V. (1968) Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America, 59, 94-101.
37. Heslop, H.E., Brenner, M.K. & Rooney, C.M. (1994) Donor T cells to treat EBV-associated lymphoma. New England Journal of Medicine, 331, 679-680.
38. Hitt, M.M., Allday, M.J., Hara, T., Karran, L., Jones, M.D., Busson, P., Tursz, T., Ernberg, I. & Griffin, B.E. (1989) EBV gene expression in an NPC-related tumour. EMBO Journal, 8, 2639-2651.
39. Hochberg, D., Souza, T., Catalina, M., Sullivan, J.L., Luzuriaga, K. & Thorley-Lawson, D.A. (2004) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. Journal of Virology, 78, 5194-5204.
40. Itin, P., Rufli, T., Rudlinger, R., Cathomas, G., Huser, B., Podvinec, M. & Gudat, F. (1988) Oral hairy leukoplakia in a HIV-negative renal transplant patient: a marker for immunosuppression?Dermatologica, 177, 126-128.
41. Kafuko, G.W. & Burkitt, D.P. (1970) Burkitt's lymphoma and malaria. International Journal of Cancer, 6, 1-9.
42. Kafuko, G.W., Henderson, B.E., Kirya, B.G., Munube, G.M., Tukei, P.M., Day, N.E., Henle, G., Henle, W., Morrow, R.H., Pike, M.C., Smith, P.G. & Williams, E.H. (1972) Epstein-Barr virus antibody levels in children from the West Nile District of Uganda. Report of a field study. Lancet, 1, 706-709.
43. Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G.W. & Kempkes, B. (1999) The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. Journal of Virology, 73, 4481-4484.
44. Kalter, S.P., Riggs, S.A., Cabanillas, F., Butler, J.J., Hagemeister, F.B., Mansell, P.W., Newell, G.R., Velasquez, W.S., Salvador, P., Barlogie, B., Rios, A. & Hersh, E.M. (1985) Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males. Blood, 66, 655-659.
45. Kang, M.S., Soni, V., Bronson, R. & Kieff, E. (2008) Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice. Journal of Virology, 82, 4180-4183.
46. Kaschka-Dierich, C., Adams, A., Lindahl, T., Bornkamm, G.W., Bjursell, G., Klein, G., Giovanella, B.C. & Singh, S. (1976) Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature, 260, 302-306.
47. Kelly, G., Bell, A. & Rickinson, A. (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nature Medicine, 8, 1098-1104.
48. Kelly, G.L., Long, H.M., Stylianou, J., Thomas, W.A., Leese, A., Bell, A.I., Bornkamm, G.W., Mautner, J., Rickinson, A.B. & Rowe, M. (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathogens, 5, e1000341.
49. Kennedy, G., Komano, J. & Sugden, B. (2003) Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proceedings of the National Academy of Sciences of the United States of America, 100, 14269-14274.
50. Khan, G., Miyashita, E.M., Yang, B., Babcock, G.J. & Thorley-Lawson, D.A. (1996) Is EBV persistence in vivo a model for B cell homeostasis?Immunity, 5, 173-179.
51. Klein, G. (1983) Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell, 32, 311-315.
52. Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K. & Kuppers, R. (1995) Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Molecular Medicine, 1, 495-505.
53. Knight, J.S., Lan, K., Subramanian, C. & Robertson, E.S. (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. Journal of Virology, 77, 4261-4272.
54. Komano, J., Maruo, S., Kurozumi, K., Oda, T. & Takada, K. (1999) Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. Journal of Virology, 73, 9827-9831.
55. Laichalk, L.L. & Thorley-Lawson, D.A. (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. Journal of Virology, 79, 1296-1307.
56. Lerner, M.R., Andrews, N.C., Miller, G. & Steitz, J.A. (1981) Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America, 78, 805-809.
57. Li, Z., Van Calcar, S., Qu, C., Cavenee, W.K., Zhang, M.Q. & Ren, B. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 8164-8169.
58. Long, H.M., Taylor, G.S. & Rickinson, A.B. (2011) Immune defence against EBV and EBV-associated disease. Current Opinion in Immunology, 23, 258-264.
59. Maier, S., Staffler, G., Hartmann, A., Hock, J., Henning, K., Grabusic, K., Mailhammer, R., Hoffmann, R., Wilmanns, M., Lang, R., Mages, J. & Kempkes, B. (2006) Cellular target genes of Epstein-Barr virus nuclear antigen 2. Journal of Virology, 80, 9761-9771.
60. Manolov, G. & Manolova, Y. (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature, 237, 33-34.
61. Marquitz, A.R., Mathur, A., Nam, C.S. & Raab-Traub, N. (2011) The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology, 412, 392-400.
62. Merchant, M., Caldwell, R.G. & Longnecker, R. (2000) The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. Journal of Virology, 74, 9115-9124.
63. Moosmann, A., Bigalke, I., Tischer, J., Schirrmann, L., Kasten, J., Tippmer, S., Leeping, M., Prevalsek, D., Jaeger, G., Ledderose, G., Mautner, J., Hammerschmidt, W., Schendel, D.J. & Kolb, H.J. (2010) Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood, 115, 2960-2970.
64. Nanbo, A., Inoue, K., Adachi-Takasawa, K. & Takada, K. (2002) Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO Journal, 21, 954-965.
65. Nanbo, A., Sugden, A. & Sugden, B. (2007) The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO Journal, 26, 4252-4262.
66. Nilsson, K. & Ponten, J. (1975) Classification and biological nature of established human hematopoietic cell lines. International Journal of Cancer, 15, 321-341.
67. Nowell, P.C. & Hungerford, D.A. (1960) Chromosome studies on normal and leukemic human leukocytes. Journal of the National Cancer Institute, 25, 85-109.
68. Nussenzweig, A. & Nussenzweig, M.C. (2011) Origin of chromosomal translocations in lymphoid cancer. Cell, 141, 27-38.
69. Old, L.J., Boyse, E.A., Oettgen, H.F., Harven, E.D., Geering, G., Williamson, B. & Clifford, P. (1966) Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America, 56, 1699-1704.
70. Pfeffer, S., Zavolan, M., Grasser, F.A., Chien, M., Russo, J.J., Ju, J., John, B., Enright, A.J., Marks, D., Sander, C. & Tuschl, T. (2004) Identification of virus-encoded microRNAs. Science, 304, 734-736.
71. Pope, J.H., Horne, M.K. & Scott, W. (1968) Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. International Journal of Cancer, 3, 857-866.
72. Pratt, Z.L., Kuzembayeva, M., Sengupta, S. & Sugden, B. (2009) The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology, 386, 387-397.
73. Purtilo, D.T., Szymanski, I., Bhawan, J., Yang, J.P., Hutt, L.M., Boto, W., DeNicola, L., Maier, R. & Thorley-Lawson, D. (1978) Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet, 1, 798-801.
74. Rastelli, J., Homig-Holzel, C., Seagal, J., Muller, W., Hermann, A.C., Rajewsky, K. & Zimber-Strobl, U. (2008) LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood, 111, 1448-1455.
75. Rooney, C.M., Smith, C.A., Ng, C.Y., Loftin, S., Li, C., Krance, R.A., Brenner, M.K. & Heslop, H.E. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein- Barr-virus-related lymphoproliferation. Lancet, 345, 9-13.
76. Rowe, D.T., Rowe, M., Evan, G.I., Wallace, L.E., Farrell, P.J. & Rickinson, A.B. (1986) Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO Journal, 5, 2599-2607.
77. Rowe, M., Rowe, D.T., Gregory, C.D., Young, L.S., Farrell, P.J., Rupani, H. & Rickinson, A.B. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO Journal, 6, 2743-2751.
78. Ruf, I.K., Rhyne, P.W., Yang, H., Borza, C.M., Hutt-Fletcher, L.M., Cleveland, J.L. & Sample, J.T. (1999) Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Molecular and Cellular Biology, 19, 1651-1660.
79. Samanta, M., Iwakiri, D. & Takada, K. (2008) Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene, 27, 4150-4160.
80. Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M.N., Shire, K., Nguyen, T., Zhang, R.G., Liao, J., Lee, W., Edwards, A.M., Arrowsmith, C.H. & Frappier, L. (2005) Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Molecular Cell, 18, 25-36.
81. Schubach, W.H., Hackman, R., Neiman, P.E., Miller, G. & Thomas, E.D. (1982) A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood, 60, 180-187.
82. Shibata, D., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S. & Weiss, L.M. (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. American Journal of Pathology, 139, 469-474.
83. Shope, T., Dechairo, D. & Miller, G. (1973) Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proceedings of the National Academy of Sciences of the United States of America, 70, 2487-2491.
84. Smith, P.R., de Jesus, O., Turner, D., Hollyoake, M., Karstegl, C.E., Griffin, B.E., Karran, L., Wang, Y., Hayward, S.D. & Farrell, P.J. (2000) Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. Journal of Virology, 74, 3082-3092.
85. Sompallae, R., Callegari, S., Kamranvar, S.A. & Masucci, M.G. (2011) Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes. PLoS ONE, 5, e12052.
86. Souza, T.A., Stollar, B.D., Sullivan, J.L., Luzuriaga, K. & Thorley-Lawson, D.A. (2005) Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 18093-18098.
87. Souza, T.A., Stollar, B.D., Sullivan, J.L., Luzuriaga, K. & Thorley-Lawson, D.A. (2007) Influence of EBV on the peripheral blood memory B cell compartment. Journal of Immunology, 179, 3153-3160.
88. de Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P. & Henle, W. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature, 274, 756-761.
89. Toczyski, D.P., Matera, A.G., Ward, D.C. & Steitz, J.A. (1994) The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 91, 3463-3467.
90. Tovey, M.G., Lenoir, G. & Begon-Lours, J. (1978) Activation of latent Epstein-Barr virus by antibody to human IgM. Nature, 276, 270-272.
91. Vereide, D.T. & Sugden, B. (2011) Lymphomas differ in their dependence on Epstein-Barr virus. Blood, 117, 1977-1985.
92. Wang, D., Liebowitz, D. & Kieff, E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
93. Weiss, L.M., Movahed, L.A., Warnke, R.A. & Sklar, J. (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New England Journal of Medicine, 320, 502-506.
94. White, R.E., Groves, I.J., Turro, E., Yee, J., Kremmer, E. & Allday, M.J. (2011) Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS ONE, 5, e13979.
95. WHO. (1997) lARC Monographs on The Evaluation of Carcinogenic Risks to Humans: Volume 70: Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. IARC, Lyon, France.
96. WHO. (2011) lARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 100: A Review of Human Carcinogens, Part B: Biological Agents. IARC, Lyon, France.
97. Wilkie, G.M., Taylor, C., Jones, M.M., Burns, D.M., Turner, M., Kilpatrick, D., Amlot, P.L., Crawford, D.H. & Haque, T. (2004) Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases. Journal of Immunotherapy, 27, 309-316.
98. Wilson, J.B., Bell, J.L. & Levine, A.J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal, 15, 3117-3126.
99. Wolf, H., Hausen, H.z. & Becker, V. (1973) EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biology, 244, 245-247.
100. Xue, S.A., Labrecque, L.G., Lu, Q.L., Ong, S.K., Lampert, I.A., Kazembe, P., Molyneux, E., Broadhead, R.L., Borgstein, E. & Griffin, B.E. (2002) Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. International Journal of Cancer, 99, 635-643.
101. Yates, J., Warren, N., Reisman, D. & Sugden, B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proceedings of the National Academy of Sciences of the United States of America, 81, 3806-3810.
102. Zimber-Strobl, U. & Strobl, L.J. (2001) EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Seminars in Cancer Biology, 11, 423-434.